Ergot alkaloid exposure during gestation alters: 3. Fetal growth, muscle fiber development, and miRNA transcriptome1
- 3 May 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 97 (7) , 3153-3168
Abstract
The objective of this study was to assess how exposure to ergot alkaloids during 2 stages of gestation alters fetal growth, muscle fiber formation, and miRNA expression. Pregnant ewes (n = 36; BW = 83.26 ± 8.14 kg; 4/group; 9 groups) were used in a 2 × 2 factorial arrangement with 2 tall fescue seed treatments [endophyte-infected (E+) vs. endophyte-free (E−)] fed during 2 stages of gestation (MID, days 35 to 85 vs. LATE, days 86 to 133), which created 4 possible treatments (E−/E−, E+/E−, E−/E+, or E+/E+). Ewes were individually fed a total mixed ration containing E+ or E− fescue seed according to treatment assignment. Terminal surgeries were conducted on day 133 of gestation for the collection of fetal measurements and muscle samples. Data were analyzed as a 2 × 2 factorial with fescue treatment, stage of gestation, and 2-way interaction as fixed effects. Fetuses exposed to E+ seed during LATE gestation had reduced (P = 0.0020) fetal BW by 10% compared with E− fetuses; however, fetal body weight did not differ (P = 0.41) with E+ exposure during MID gestation. Fetuses from ewes fed E+ seed during MID and LATE gestation tended to have smaller (P = 0.058) kidney weights compared with E− fetuses. Liver weight was larger (P = 0.0069) in fetuses fed E− during LATE gestation compared with E+. Fetal brain weight did not differ by fescue treatment fed during MID (P = 0.36) or LATE (P = 0.40) gestation. The percentage of brain to empty body weight (EBW) was greater (P = 0.0048) in fetuses from ewes fed E+ fescue seed during LATE gestation, which is indicative of intrauterine growth restriction (IUGR). Primary muscle fiber number was lower (P = 0.0005) in semitendinosus (STN) of fetuses exposed to E+ during MID and/or LATE gestation compared with E−/E−. miRNA sequencing showed differential expression (P < 0.010) of 6 novel miRNAs including bta-miR-652_R+1, mdo-miR-22-3p, bta-miR-1277_R-1, ppy-miR-133a_L+1_1ss5TG, hsa-miR-129-1-3p, and ssc-miR-615 in fetal STN muscle. These miRNA are associated with glucose transport, insulin signaling, intracellular ATP, hypertension, or adipogenesis. This work supports the hypothesis that E+ tall fescue seed fed during late gestation reduces fetal weight and causes asymmetrical growth, which is indicative of IUGR. Changes in primary fiber number and miRNA of STN indicate that exposure to E+ fescue fed during MID and LATE gestation alters fetal muscle development that may affect postnatal muscle growth and meat quality.Keywords
Funding Information
- USDA Agriculture and Food Research Initiative Competitive (2015-67015-23218)
- Clemson University Division of Research, NIH EPIC COBRE (P20GM109094)
- NIH SCBiocraft COBRE (5P20RR021949-03)
This publication has 75 references indexed in Scilit:
- Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin ResistancePLOS ONE, 2013
- Birth and expression evolution of mammalian microRNA genesGenome Research, 2012
- Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytesBritish Journal of Pharmacology, 2011
- Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone, and ligament/tendon studiesMicroscopy Research and Technique, 2010
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- Evidence of MyomiR network regulation of β-myosin heavy chain gene expression during skeletal muscle atrophyPhysiological Genomics, 2009
- JAK2/STAT2/STAT3 Are Required for Myogenic DifferentiationJournal of Biological Chemistry, 2008
- PRDM16 controls a brown fat/skeletal muscle switchNature, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- JAK1–STAT1–STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblastsJournal of Cell Biology, 2007